Healthcare -
Medical - Devices - NASDAQ - US
$ 10.04
-0.692 %
$ 656 M
Market Cap
-16.46
P/E
Price Target
Average
2.09%
Revenue Forecast
Estimate
20.35%
EBIT
Estimate
54.75%
Net Income
Estimate
129.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bioventus Inc.
Wall Street analysts predict an average 1-year price target for BVS of $10.2 , with forecasts ranging from
a
low of
$8 to a high of $12 .
BVS Lowest Price Target
Wall Street Target
8 USD
-20.32%
BVS Average Price Target
Wall Street Target
10.2 USD
2.09%
BVS Highest Price Target
Wall Street Target
12 USD
19.52%
REVENUE FORECAST
Revenue Forecast Chart BVS
EBIT FORECAST
EBIT Forecast Chart BVS
NET INCOME FORECAST
Net Income Chart BVS